Supplemental Financial Data (Tables)

6 Months Ended

Jun. 30, 2024

Supplemental Financial Data [Abstract]

Inventories

Inventories

Our inventory consisted of the following (in thousands):

	June 30, 2024		December 31, 2023
Raw materials:
Raw materials - clinical	$	22,211	$	20,985
Raw materials - commercial		2,412		1,809
Total raw materials		24,623		22,794
Work in process		3,614		5,477
Finished goods		486		154
Total inventories	$	28,723	$	28,425

Accrued Liabilities

Accrued Liabilities

Our accrued liabilities consisted of the following (in thousands):

	June 30, 2024		December 31, 2023
Clinical development expenses	$	82,017	$	105,967
In-licensing expenses		10,603		7,454
Commercial expenses		4,583		4,875
Other miscellaneous expenses		17,127		29,598
Total accrued liabilities	$	114,330	$	147,894